Search hospitals > Iowa > Clive

Medical Oncology and Hematology Associates-West Des Moines

Claim this profile
Clive, Iowa 50325
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
394 reported clinical trials
2 medical researchers
Photo of Medical Oncology and Hematology Associates-West Des Moines in ClivePhoto of Medical Oncology and Hematology Associates-West Des Moines in Clive

Summary

Medical Oncology and Hematology Associates-West Des Moines is a medical facility located in Clive, Iowa. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Medical Oncology and Hematology Associates-West Des Moines is involved with conducting 394 clinical trials across 478 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.

Area of expertise

1Cancer
Global Leader
Medical Oncology and Hematology Associates-West Des Moines has run 138 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Medical Oncology and Hematology Associates-West Des Moines has run 68 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
ER positive
HER2 negative

Top PIs

Clinical Trials running at Medical Oncology and Hematology Associates-West Des Moines

Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Bladder Carcinoma
Bladder Cancer
Colorectal Cancer
Renal Cell Carcinoma
Multiple Myeloma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Medical Oncology and Hematology Associates-West Des Moines?
Medical Oncology and Hematology Associates-West Des Moines is a medical facility located in Clive, Iowa. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Medical Oncology and Hematology Associates-West Des Moines is involved with conducting 394 clinical trials across 478 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.
Where is Medical Oncology and Hematology Associates-West Des Moines located?
Medical Oncology & Hematology Associates is situated at 1221 Pleasant St, Des Moines, IA 50309, within the MercyOne Cancer Center at the MercyOne Des Moines Medical Center complex. For access, use the main entrance of the MercyOne Des Moines Medical Center and follow the signs to the West Building. The office is on the first floor of the West Building.
Who should I call to ask about financial aid or insurance network?
**Medical Oncology and Hematology Associates-West Des Moines Hospital Financial Assistance Overview:** - **MercyOne Financial Assistance:** Eligible patients can apply for financial aid through MercyOne's Financial Assistance Policy. To qualify, applicants must provide details on household income and expenses, targeting uninsured or underinsured individuals with financial resources and/or income at or below 400% of the Federal Poverty Level. A list of providers covered by this policy is available. - **UnityPoint Health Financial Assistance:** UnityPoint Health offers financial assistance to patients unable to afford their care. The policy includes a plain language summary, application form, and billing collections policy, with eligibility based on annual income guidelines and special circumstances considered individually. Patients seeking financial assistance are encouraged to explore options with MercyOne and UnityPoint Health.
What insurance does Medical Oncology and Hematology Associates-West Des Moines accept?
Medical Oncology and Hematology Associates (MOHA) offers comprehensive cancer care and treatment. They accept various insurance plans. For detailed information on accepted insurance plans, please contact MOHA directly or visit their website.
What awards or recognition has Medical Oncology and Hematology Associates-West Des Moines received?
**Mission Cancer + Blood (Formerly Medical Oncology and Hematology Associates-West Des Moines)** Located in Clive, Iowa, Mission Cancer + Blood was established in 1981 with a commitment to delivering immediate, compassionate care to patients facing cancer and blood disorders. Over the years, it has expanded its reach through numerous locations and partnerships with leading health systems, establishing itself as a benchmark for accessible, high-quality cancer care across Iowa.